• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Therapeutic efficacy and mechanism of heat-sensitive moxibustion for adjuvant treatment of depression in Parkinson disease

    2020-02-28 08:46:08WangXiaomei王笑媚RongChunjiao榮春嬌

    Wang Xiao-mei (王笑媚), Rong Chun-jiao (榮春嬌)

    Lishui Second People’s Hospital, Zhejiang 323000, China

    Abstract

    Keywords: Moxibustion Therapy; Moxa Stick Moxibustion; Heat-sensitive Moxibustion; Quality of Life; Mental Status and Dementia Tests; Parkinson Disease; Depression

    Parkinson disease (PD) is a chronic and progressive neurodegenerative disease pathologically characterized by the loss of dopaminergic neurons in the substantia nigra and the dysfunction of dopamine (DA) pathway in the striatum, and clinically characterized by bradykinesia, myotonia, tremor, abnormal posture and gait[1].As the disease progresses, non-motor symptoms of PD also gradually occur, among which, depression is more common, with the incidence rate as high as 35%-50%[2].Parkinson disease with depression (PDD)can lead to the decrease of cognitive ability, the decrease of daily quality of life and the increase of suicide rate, which has a very negative impact on families and society[3].For PDD, DA receptor agonists,tricyclic antidepressants, and 5-hydroxytryptamine(5-HT) reuptake inhibitors are mainly used in clinic, and appropriately combined with cognitive behavioral therapy, electric shock therapy, psychotherapy and other auxiliary therapies[4].However, the efficacy of drug is limited, the action is slow, the treatment course is long, the cost is high, and the adverse reactions are obvious, while the curative effect is not stable.The auxiliary therapies lack of professionals, and its clinical popularization rate needs to be improved[5].

    PDD belongs to tremor syndrome and depression syndrome in traditional Chinese medicine (TCM).TCM has a certain effect in treating PDD[6-7], and patients have better compliance.As one kind of the TCM therapies, moxibustion has been reported in many clinical studies in the treatment of PD and depression[8-9], and its safety has been widely recognized.However, there are few reports on the clinical efficacy and mechanism of moxibustion for PDD.

    In this study, we observed the clinical efficacy of heat-sensitive moxibustion for the treatment of PDD,and its effects on the levels of neurotransmitters and inflammatory factors.

    1 Clinical Materials

    1.1 Case selection

    1.1.1 Diagnostic criteria in Western medicine

    Met the diagnostic criteria of PD in theChinese Guideline for Treatment of Parkinson Disease(3rd edition)[10].Met the diagnostic criteria of depression in the 3rd edition ofChinese Classification and Diagnosis of Mental Diseases(Classification of Mental Disorders)[11].

    1.1.2 Criteria for syndrome differentiation of traditional Chinese medicine (TCM)

    Syndrome differentiation classification referred to the criteria of syndrome of qi and blood depletion in theGuiding Principles for Clinical Study of New Chinese Medicines[12].Primary manifestations: tremor of head or limbs, less movement, over-thinking and being anxious, palpitations and timidity.Secondary manifestations: hypomimia, dim complexion, dizziness and spiritlessness, anorexia, a pale teeth-printed tongue with white coating, deep pulse or weak pulse.

    1.2 Inclusion criteria

    Those who met the above diagnostic criteria of PD in Western medicine and syndrome of qi and blood depletion for syndrome differentiation of TCM; aged 40-80 years; Hamilton depression scale-17(HAMD-17) >13 points[13]; agreed to participate in this trial and signed informed consent.

    1.3 Exclusion criteria

    Patients with non-PD diseases such as hepatolenticular degeneration, hepatic encephalopathy,essential tremor; those with severe diseases of heart,brain, liver or kidney; women during pregnancy or lactation; those were unconscious or unable to cooperate with the trial; those who were allergic to the medication.

    1.4 Statistical methods

    All data were statistically analyzed by the SPSS version 20.0 statistical software.Chi-square test was applied to the comparison of counting data.Measurement data were first tested for normality and homogeneity of variance.Those in normal distribution and had homogeneous variance were expressed as mean ± standard deviation (±s), andt-test was applied.T’-test was applied for data with uneven variance.If data did not meet the normal distribution,non-parametric test was applied.P<0.05 was considered to indicate a statistically significant difference.

    1.5 General data

    A total of 80 patients who met the inclusion criteria of PDD were enrolled from our hospital between September 2016 and January 2019.All patients were randomly divided into an observation group and a control group by the random number table, with 40 cases in each group.There was no dropout case during the study.The patients in the observation group were aged between 48 and 80 years, with the shortest duration of 9 months and the longest of 93 months.The patients in the control group were aged between 51 and 80 years, with the shortest duration of 6 months and the longest of 92 months.There were no significant differences in the data of gender, age and duration of disease between the two groups (allP>0.05), indicating that the two groups were comparable (Table 1).

    Table 1.Comparison of general data between the two groups

    2 Treatment Methods

    2.1 Control group

    Patients in the control group received conventional symptomatic treatment of Western medicine, and the efficacy was observed after continuous 2-month treatment.

    Anti-PD treatment: Oral levodopa and benserazide hydrochloride tablets (national drug registration number: H10930198, Shanghai Roche Pharmaceutical Co., Ltd., China), starting at 0.125 g per time, three times a day.Added 0.125 g per week after starting the medicine, and maintained the dosage after the symptoms improved.

    Antidepressant treatment: Oral paroxetine tablets(national drug registration number: H10950043,Sino-American Tianjin Shike Pharmaceutical Co., Ltd.,China), 20 mg, once a day.

    2.2 Observation group

    2.2.1 Medications

    The observation group received the same medications as the control group.

    2.2.2 Heat-sensitive moxibustion

    Acupoints: Qihai (CV 6) and bilateral Xuehai (SP 10),Zusanli (ST 36), Xinshu (BL 15) and Pishu (BL 20).

    Moxa stick specifications: Hwato Brand pure moxa sticks of 1.8 cm in diameter and 20 cm in length were used for moxibustion (Nanyang Wolong Chinese Medicine Moxa Factory, China).

    Methods: Acupoint locations referred to theScience of Meridians and Acupoints[14].The heat-sensitive moxibustion operation referred to theAcupoint Heatsensitization Moxibustion:A New Moxibustion Therapy[15].The patient took a supine position, exposing the acupoints.After receiving moxibustion at frontal points, the patient changed to the prone position.The physician sought heat-sensitized points first, which was to apply circling moxibustion and mild moxibustion to the acupoints with an ignited moxa stick 3-5 cm away from skin.When patient felt heat penetration, heat expansion, heat transmission or heat in distant area but not in local area, that would be the heat-sensitized point.Then the physician continued to perform mild moxibustion at this heat-sensitized point till the disappearance of the heat sensitization.The physician repeated the above steps until the selected acupuncture points were completed for moxibustion in turn.The heat-sensitive moxibustion was performed once a day for 2 months.

    3 Observation of Curative Efficacy

    3.1 Observation items

    3.1.1 HAMD-17 score

    HAMD-17 was scored before and after treatment for the two groups by the same neurologist not knowing about grouping.The HAMD-17 score ranges from 0 to 53 points, and higher scores indicate more severe depressive symptoms.PD patients with a HAMD-17 score >13 points were considered to be depressed.HAMD-17 has high sensitivity and specificity that can be used for screening and severity assessment of PDD[13].

    3.1.2 Unified Parkinson's disease rating scale (UPDRS)

    UPDRS was scored before and after treatment for the two groups by the same neurologist not knowing about grouping.UPDRS consists of Ⅰ (mind, behavior and emotion), Ⅱ (activities of daily living), Ⅲ (motor examination) and Ⅳ (complications).The total score is 199 points, and the higher the score, the more severe the condition of PD patients[16].

    3.1.3 Parkinson's disease quality of life questionnaire-39 (PDQ-39)

    Before and after treatment, patients in both groups filled the PDQ-39 according to their actual situation in the last month.PDQ-39 consists of 8 dimensions,including physical activity, daily behavioral activities,mental health, humiliation, social support, cognition,communication and physical discomfort, with a total of 39 subjects and a score ranging from 0 to 156 points.The higher the score, the worse the quality of life[17].

    3.1.4 Neurotransmitter and inflammatory factors detection

    The fasting venous blood in the morning was collected before and after treatment.The serum DA,5-HT, tumor necrosis factor-α (TNF-α) and interleukin-6(IL-6) levels of the two groups were measured before and after treatment by enzyme-linked immunosorbent assay (ELISA).

    3.2 Criteria of curative efficacy

    The reduction rate of HAMD-17 score was used as the criteria of efficacy evaluation[18].

    HAMD-17 reduction rate = (Score before treatment -Score after treatment) ÷ Score before treatment ×100%.

    Cured: The main symptoms basically disappeared.HAMD-17 reduction rate ≥90%.

    Marked effect: The main symptoms were significantly improved.HAMD-17 reduction rate ≥60%, but <90%.

    Effective: The main symptoms were improved.HAMD-17 reduction rate ≥30%, but <60%.

    Invalid: The main symptoms were not obviously improved or even worse.HAMD-17 reduction rate<30%.

    3.3 Results

    3.3.1 Clinical efficacy

    The total effective rate was 95.0% in the observation group and 72.5% in the control group.The total effective rate of the observation group was higher than that of the control group (χ2=7.44,P=0.006), (Table 2).

    Table 2.Comparison of clinical efficacy between the two groups (case)

    3.3.2 HAMD-17 score

    There was no significant difference in the HAMD-17 score between the two groups before treatment(P>0.05).After treatment, the HAMD-17 scores in both groups decreased obviously (bothP<0.05), and the HAMD-17 score in the observation group was significantly lower than that in the control group(P<0.05), (Table 3).

    3.3.3 UPDRS score

    There were no significant differences in the UPDRS component and total scores between the two groups before treatment (allP>0.05).After treatment, the UPDRS component and total scores in both groups decreased significantly (allP<0.05), and all the scores in the observation group were lower than those in the control group (allP<0.05), (Table 4).

    Table 3.Comparison of the HAMD-17 score between the two groups (±s, point)

    Table 3.Comparison of the HAMD-17 score between the two groups (±s, point)

    Note: Compared with the same group before treatment, 1)P<0.05; compared with the control group after treatment, 2)P<0.05

    Group n Before treatment After treatment Observation 40 21.75±5.55 14.43±4.961)2)Control 40 21.55±5.61 17.78±4.421)

    Table 4.Comparison of UPDRS scores between the two groups (±s, point)

    Table 4.Comparison of UPDRS scores between the two groups (±s, point)

    Note: BT=Before treatment; AT=After treatment; compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Motor examination Complications Total 23.80±2.68 6.53±1.11 52.28±3.52 19.50±2.001)2) 3.83±0.781)2) 37.53±2.861)2)24.60±2.22 6.43±1.17 52.88±3.47 21.38±2.021) 4.88±0.791) 45.65±2.951)

    3.3.4 PDQ-39 score

    There was no significant difference in the PDQ-39 score between the two groups before treatment(P>0.05).After treatment, the PDQ-39 scores in both groups decreased significantly (bothP<0.05), and the PDQ-39 score in the observation group was significantly lower than that in the control group (P<0.05), (Table 5).

    3.3.5 Serum DA and 5-HT levels

    There were no significant differences in the serum DA and 5-HT levels between the two groups before treatment (bothP>0.05).After treatment, the DA and 5-HT levels in the observation group increased significantly (bothP<0.05), and were higher than those in the control group (bothP<0.05), (Table 6).

    Table 5.Comparison of the PDQ-39 score between the two groups (±s, point)

    Table 5.Comparison of the PDQ-39 score between the two groups (±s, point)

    Note: Compared with the same group before treatment, 1)P<0.05; compared with the control group after treatment, 2)P<0.05

    Observation 40 65.98±8.69 48.35±8.401)2)Control 40 64.10±7.96 56.20±7.591)

    Table 6.Comparison of the serum DA and 5-HT levels between the two groups (±s)

    Table 6.Comparison of the serum DA and 5-HT levels between the two groups (±s)

    Note: Compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Group n DA (pg/mL) 5-HT (ng/mL)Before treatment After treatment Before treatment After treatment Observation 40 42.73±3.51 64.75±4.071)2) 158.21±21.89 256.95±26.541)2)Control 40 42.12±3.21 42.53±3.94 161.26±22.74 165.27±23.76

    3.3.6 Serum TNF-α and IL-6 levels

    There were no significant differences in the serum TNF-α and IL-6 levels between the two groups before treatment (bothP>0.05).After treatment, the TNF-α and IL-6 levels in the observation group decreased significantly (bothP<0.05), and were lower than those in the control group (bothP<0.05), (Table 7).

    3.3.7 Adverse reactions

    During the treatment, there were 2 cases of mild diarrhea, 2 cases of nausea and vomiting and 3 cases of dizziness in the control group.There was 1 case of vomiting occurred in the observation group.The incidence of adverse reactions in the control group was 17.5%, which was significantly higher than that in the observation group (2.5%,χ2=5.00,P=0.025).The adverse reactions in the two groups were minor and all self-relieved within a short time.After treatment, there were no obvious abnormal changes in blood, urine,stool, liver and kidney function in all participants.

    Table 7.Comparison of the TNF-α and IL-6 levels between the two groups (±s, pg/mL)

    Table 7.Comparison of the TNF-α and IL-6 levels between the two groups (±s, pg/mL)

    Note: Compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Group n TNF-α IL-6 Before treatment After treatment Before treatment After treatment Observation 40 432.93±59.48 333.87±45.241)2) 26.96±3.08 18.90±3.351)2)Control 40 445.98±53.86 430.06±49.03 26.28±2.86 25.74±3.08

    4 Discussion

    The pathogenesis of PDD is not clear.At present, it is believed that it is mainly caused by endogenous biological factors and exogenous psychological factors.Study showed that there was no significant correlation between the severity of depression and the progress of PD, and some of the depression symptoms appeared before motor symptoms, some occurred at the same time, and some after medications[19].It was clear that although bad mind and emotions such as delusion,despair and inferiority caused by the aggravation of motor dysfunction and the decline of social function and adaptability could indeed lead to the occurrence of depressive symptoms, the endogenous biological factors were the most primary cause of PDD.

    Abnormalities in neurotransmitters such as DA and 5-HT play an important role in the occurrence and progress of PDD.DA is a neurotransmitter involved in the regulation of both motor function and emotional activity.The main biochemical change of PD is the significant decrease of DA content in the brain.The typical motor symptoms of PD only occur when the dopaminergic neurons in the substantia nigra is reduced by more than 50% and DA content in the basal ganglia is reduced by more than 80%.Decreased DA neurons in the central system can also lead to reduced or lost happiness, apathy and the decrease of consciousness activities.Both PD patients and patients with depression have corpus striatum DA system dysfunction.Depression symptoms are one of the basic manifestations of PD patients with impaired dopaminergic pathways in the central frontal cortex[20].In addition to dopaminergic system, PD with depression is also related to abnormal 5-HT system.Clinical study showed that the serum 5-HT level was significantly reduced in patients with PD and depression, and 5-HT receptor antagonists could improve depressive symptoms in PD patients[19].5-HT transporters are also related to PDD, and can reflect the functional status of 5-HT neurons.It was found that the marker signal of 5-HT transporter in the nucleus raphes dorsalis was significantly reduced in the brain specimens of PD patients, indicating that there was 5-HT neuron dysfunction in PD patients[21].In addition, the feedback mechanism of 5-HT on DA is also involved in pathogenic process of PDD.Under physiological conditions, 5-HT inhibits the release of DA, while with the decrease of the DA level, the 5-HT level decreases, leading to the onset of PDD.

    Recent studies suggested that inflammatory factors such as TNF-α and IL-6 might also cause depression in PD patients.It was found that the serum TNF-α and IL-6 levels in PDD patients were significantly lower than those in healthy participants.After treatment, the levels of inflammatory factors were corrected to some extent[22], which suggested that the levels of inflammatory factors might be related to cognitive dysfunction in patients with PDD and might reflect the severity of cognitive impairment.Inflammatory cytokines may induce dopaminergic neuron cell damage by stimulating microglia, and also lead to apoptosis by combining with dopaminergic neuron cells and participate in the pathogenesis of PD[23].At the same time, over-expressed inflammatory cytokines aggravate immune damage, affect the expressions of hypothalamic-pituitary-adrenal cortex axis hormones and neurotransmitters such as DA and 5-HT, and induce emotional disorders such as depression[24].

    According to the clinical manifestation of PDD, it falls under the category of tremor syndrome and depression syndrome in TCM.There is no consensus on pathogenesis and TCM pattern.For example, Song QY[25]advocated that it should be divided into three patterns:yin deficiency of liver and kidney, internal stirring of deficient wind; yang deficiency of spleen and kidney,internal blockade of phlegm stagnation; deficiency of both qi and blood, static blood blocking collaterals.However, study on TCM pattern showed that syndrome of qi and blood depletion was one of the most common syndromes in PD patients[26], and syndrome of qi and blood depletion of heart and spleen was a common pattern in patients with depression[27].PD patients with emotional disorders were more likely to have qi deficiency[28].It is clear that deficiency of both qi and blood syndrome is one of common syndromes in clinic.Therefore, the treatment principles should be benefiting qi for promoting production of blood and invigorating heart and spleen.

    The heat-sensitive moxibustion is a new therapy characterized by applying suspended moxibustion to heat-sensitized acupoints.It has effects of traditional moxibustion such as warming for unblocking, warming for invigoration and mutual application of unblockinginvigorating.It is also suitable for deficiency syndrome,cold syndrome and meridian qi and blood blockage syndrome.In addition, the heat-sensitive moxibustion pays more attention to the transmission of meridian provoked by moxibustion, so that qi can reach the disease location, thus producing a more significant therapeutic effect compared with the traditional moxibustion.

    In this study, Qihai (CV 6), Xuehai (SP 10), Zusanli(ST 36), Xinshu (BL 15) and Pishu (BL 20) were selected for moxibustion.Qihai (CV 6) is the Yuan-Primary point of Huang (the region around the navel), the sea of qi generation and the gathering place of primordial qi.Moxibustion at Qihai (CV 6) has the effect of benefiting qi and regulating qi flow.Xuehai (SP 10) can activate blood and resolve stasis, replenish and nourish blood,and lead blood back to the channel.For treating blood-related diseases, combination of Xuehai (SP 10)and Qihai (CV 6) has the effects of replenishing and nourishing blood, moving qi and activating blood, and promoting meridians and dissipating stasis.Zusanli(ST 36) is the He-Sea point of the Stomach Meridian and the Lower He-Sea point of stomach, with the effect of invigorating spleen and stomach, harmonizing qi and blood, strengthening vital qi and primordial energy.Xinshu (BL 15) and Pishu (BL 20) are the Back-Shu points of heart and spleen, respectively.They can invigorate heart and spleen and promote the derivation of qi and blood.They are the key points to treat diseases of heart and spleen.The combination of the above five acupoints can produce the effect of benefiting qi and activating qi flow, nourishing blood and promoting blood circulation, and invigorating spleen for benefiting heart.

    Results of this study showed that the clinical effective rate of the observation group was significantly higher than that of the control group.After treatment, the HAMD-17 score, the UPDRS component and total scores in the observation group were improved obviously, and superior to those in the control group.The PDQ-39 score in the observation group decreased obviously after treatment, and was lower than that in the control group.The serum DA and 5-HT levels in the observation group increased significantly after treatment, and the TNF-α and IL-6 levels decreased significantly, which were all significantly different from those in the control group.The above results indicated that heat-sensitive moxibustion had certain assistant effect in treating PDD that could significantly improve clinical symptoms.It had obvious antidepressant effect,and could improve quality of life of patient, which may be related to the up-regulation of DA and 5-HT levels and the down-regulation of TNF-α and IL-6 levels.

    大话2 男鬼变身卡| 自拍偷自拍亚洲精品老妇| 国产精品久久久久久精品电影| 欧美一区二区亚洲| 又爽又黄无遮挡网站| 天堂av国产一区二区熟女人妻| 在线天堂最新版资源| 97人妻精品一区二区三区麻豆| 国产成人精品婷婷| 好男人在线观看高清免费视频| 日日啪夜夜爽| 亚洲av二区三区四区| 亚洲精品成人久久久久久| 亚洲av成人av| 人妻少妇偷人精品九色| 成人午夜精彩视频在线观看| 国产黄色免费在线视频| 成人特级av手机在线观看| 成年人午夜在线观看视频 | 老司机影院毛片| 男人舔女人下体高潮全视频| 91精品伊人久久大香线蕉| 日韩一区二区三区影片| 国产成人一区二区在线| 亚洲熟女精品中文字幕| av在线播放精品| 干丝袜人妻中文字幕| 国产亚洲精品av在线| 日韩一本色道免费dvd| 国产国拍精品亚洲av在线观看| 禁无遮挡网站| 成人欧美大片| 熟女电影av网| 国产成年人精品一区二区| 精品久久久精品久久久| 欧美日韩亚洲高清精品| 日韩欧美国产在线观看| 乱系列少妇在线播放| 欧美日韩国产mv在线观看视频 | 亚洲第一区二区三区不卡| 亚洲真实伦在线观看| 亚洲一级一片aⅴ在线观看| 好男人视频免费观看在线| 一级av片app| 一个人看视频在线观看www免费| 只有这里有精品99| 丝袜美腿在线中文| 尤物成人国产欧美一区二区三区| 国产老妇女一区| 搡女人真爽免费视频火全软件| 69av精品久久久久久| 欧美日韩亚洲高清精品| www.av在线官网国产| av免费观看日本| 校园人妻丝袜中文字幕| 女的被弄到高潮叫床怎么办| 欧美区成人在线视频| 免费av毛片视频| 国模一区二区三区四区视频| 国产在线一区二区三区精| 一个人看的www免费观看视频| 久久精品久久久久久噜噜老黄| 女人十人毛片免费观看3o分钟| 亚洲精品国产av蜜桃| 欧美不卡视频在线免费观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 久久久色成人| 欧美潮喷喷水| 天天躁夜夜躁狠狠久久av| 男女边吃奶边做爰视频| 99热全是精品| 黄色一级大片看看| 日韩制服骚丝袜av| 老司机影院成人| 青春草视频在线免费观看| 91久久精品电影网| av在线天堂中文字幕| 少妇人妻精品综合一区二区| 中文资源天堂在线| 搡女人真爽免费视频火全软件| 欧美成人一区二区免费高清观看| 男女那种视频在线观看| 亚洲精品自拍成人| 欧美zozozo另类| 日本三级黄在线观看| 成人亚洲欧美一区二区av| 97超视频在线观看视频| 最近的中文字幕免费完整| 国产久久久一区二区三区| 色5月婷婷丁香| 国产av在哪里看| 校园人妻丝袜中文字幕| 国产 一区 欧美 日韩| 国产一级毛片七仙女欲春2| 又粗又硬又长又爽又黄的视频| 国产精品久久久久久精品电影小说 | 国产黄a三级三级三级人| 亚洲欧美中文字幕日韩二区| 国产成人freesex在线| 欧美bdsm另类| 久久久久九九精品影院| 久久久久久久久中文| 日本与韩国留学比较| av在线播放精品| 高清在线视频一区二区三区| 国产高潮美女av| 成人特级av手机在线观看| 麻豆av噜噜一区二区三区| 精品少妇黑人巨大在线播放| 精品一区二区免费观看| 日韩 亚洲 欧美在线| 日韩在线高清观看一区二区三区| 亚洲成人中文字幕在线播放| 亚洲精品国产av成人精品| 美女被艹到高潮喷水动态| 汤姆久久久久久久影院中文字幕 | 国产色婷婷99| 国产白丝娇喘喷水9色精品| 国产午夜精品一二区理论片| 国产亚洲91精品色在线| 91精品伊人久久大香线蕉| 亚洲婷婷狠狠爱综合网| 久久人人爽人人片av| 亚洲精华国产精华液的使用体验| 中文天堂在线官网| 久久精品综合一区二区三区| 人妻少妇偷人精品九色| 三级国产精品片| 成人美女网站在线观看视频| 色综合色国产| 国产男女超爽视频在线观看| 日韩国内少妇激情av| 久久久久久久久久人人人人人人| 中文精品一卡2卡3卡4更新| 午夜激情福利司机影院| 老司机影院毛片| xxx大片免费视频| 最近的中文字幕免费完整| 搞女人的毛片| 天堂√8在线中文| 人妻系列 视频| 女人久久www免费人成看片| 亚洲精品乱久久久久久| 亚洲一区高清亚洲精品| 成年女人看的毛片在线观看| 综合色丁香网| 成人美女网站在线观看视频| 亚洲精品成人久久久久久| 性色avwww在线观看| 精品国内亚洲2022精品成人| 国产午夜精品久久久久久一区二区三区| 亚洲aⅴ乱码一区二区在线播放| 丝袜喷水一区| 欧美日韩在线观看h| 午夜福利视频精品| 国产成人精品一,二区| 国产黄色免费在线视频| 最近手机中文字幕大全| 精品少妇黑人巨大在线播放| 2018国产大陆天天弄谢| 男插女下体视频免费在线播放| 久久久色成人| 看非洲黑人一级黄片| 亚洲成人中文字幕在线播放| 国产成人a∨麻豆精品| 国产成人精品一,二区| 亚洲真实伦在线观看| 六月丁香七月| 国产成人一区二区在线| 国产欧美另类精品又又久久亚洲欧美| 最近2019中文字幕mv第一页| 久久久久久久久久人人人人人人| 国产精品女同一区二区软件| 夜夜爽夜夜爽视频| 少妇人妻一区二区三区视频| 国产精品久久久久久精品电影小说 | 亚洲aⅴ乱码一区二区在线播放| 国产日韩欧美在线精品| 欧美日韩精品成人综合77777| 亚洲最大成人手机在线| 国产成人一区二区在线| 床上黄色一级片| 干丝袜人妻中文字幕| 欧美日韩综合久久久久久| 夫妻午夜视频| 国产大屁股一区二区在线视频| 亚洲精品乱码久久久久久按摩| 久久精品久久精品一区二区三区| 欧美变态另类bdsm刘玥| 精品国产三级普通话版| 国产视频内射| 精品国产露脸久久av麻豆 | 国产色婷婷99| 国产伦精品一区二区三区视频9| 久久久久精品性色| 大陆偷拍与自拍| 91久久精品国产一区二区三区| 亚洲精品乱码久久久v下载方式| 日韩欧美 国产精品| 最近中文字幕高清免费大全6| 免费少妇av软件| 亚洲自拍偷在线| 亚洲综合精品二区| 色5月婷婷丁香| 日韩欧美三级三区| 午夜精品国产一区二区电影 | 亚洲成人中文字幕在线播放| 麻豆成人午夜福利视频| 色网站视频免费| 噜噜噜噜噜久久久久久91| 色尼玛亚洲综合影院| 亚洲精品视频女| 欧美xxxx黑人xx丫x性爽| 看黄色毛片网站| 九九久久精品国产亚洲av麻豆| 亚洲成人久久爱视频| 国产成人精品福利久久| 狂野欧美激情性xxxx在线观看| 精品亚洲乱码少妇综合久久| 少妇人妻一区二区三区视频| 久久人人爽人人片av| 最近中文字幕2019免费版| 搡老乐熟女国产| 国产 一区 欧美 日韩| 国产午夜精品久久久久久一区二区三区| 国产亚洲av嫩草精品影院| 久久久久久久久久成人| 久久人人爽人人爽人人片va| 国产伦理片在线播放av一区| 亚洲国产精品专区欧美| 18禁动态无遮挡网站| 欧美精品一区二区大全| 亚洲va在线va天堂va国产| 在线播放无遮挡| 我的女老师完整版在线观看| 99热这里只有精品一区| 2021天堂中文幕一二区在线观| 毛片一级片免费看久久久久| 人妻一区二区av| 国产成年人精品一区二区| 如何舔出高潮| 国产精品福利在线免费观看| 午夜激情福利司机影院| 美女脱内裤让男人舔精品视频| 久久久久久国产a免费观看| 亚洲精品一区蜜桃| 久久久久精品久久久久真实原创| 一级av片app| 国产永久视频网站| 国产老妇伦熟女老妇高清| 国产成人精品福利久久| 一夜夜www| 国产激情偷乱视频一区二区| av免费在线看不卡| av线在线观看网站| 成人国产麻豆网| 99热这里只有是精品在线观看| 成年女人看的毛片在线观看| 一区二区三区乱码不卡18| 成人高潮视频无遮挡免费网站| 久久久久久久午夜电影| 啦啦啦韩国在线观看视频| 久久这里只有精品中国| 欧美极品一区二区三区四区| av播播在线观看一区| 国产淫片久久久久久久久| 三级经典国产精品| 在线观看美女被高潮喷水网站| 成年女人在线观看亚洲视频 | 国产亚洲精品久久久com| 国产成人精品福利久久| av在线播放精品| 亚洲精品一二三| xxx大片免费视频| 亚洲av在线观看美女高潮| 街头女战士在线观看网站| 国产淫片久久久久久久久| 国产老妇女一区| 亚洲欧美日韩卡通动漫| 少妇熟女aⅴ在线视频| 舔av片在线| 成人综合一区亚洲| 五月玫瑰六月丁香| 亚洲av成人精品一区久久| 免费播放大片免费观看视频在线观看| 欧美丝袜亚洲另类| 久久精品人妻少妇| 成年人午夜在线观看视频 | 国产免费视频播放在线视频 | 男插女下体视频免费在线播放| 国产成人精品福利久久| 免费观看无遮挡的男女| 人妻制服诱惑在线中文字幕| 午夜亚洲福利在线播放| 久久精品国产亚洲av涩爱| 狂野欧美激情性xxxx在线观看| 日韩电影二区| 国产成人精品婷婷| 国产一区有黄有色的免费视频 | 国产精品伦人一区二区| 自拍偷自拍亚洲精品老妇| 熟女人妻精品中文字幕| 纵有疾风起免费观看全集完整版 | h日本视频在线播放| 日本av手机在线免费观看| 久久久欧美国产精品| 亚洲av福利一区| 天堂影院成人在线观看| av免费在线看不卡| 亚洲不卡免费看| av国产免费在线观看| 麻豆av噜噜一区二区三区| 男人舔奶头视频| 国产淫片久久久久久久久| 精品不卡国产一区二区三区| 午夜福利在线观看吧| 国产成人freesex在线| 偷拍熟女少妇极品色| 欧美高清成人免费视频www| 亚洲自偷自拍三级| 中文字幕久久专区| 亚洲精品视频女| 色哟哟·www| 国产精品熟女久久久久浪| 精品久久久噜噜| 亚洲av男天堂| 天堂影院成人在线观看| 99热网站在线观看| videos熟女内射| 日本wwww免费看| 成年av动漫网址| 日韩欧美精品v在线| 熟女人妻精品中文字幕| 亚洲精品乱码久久久久久按摩| 插阴视频在线观看视频| 美女脱内裤让男人舔精品视频| 大片免费播放器 马上看| 看免费成人av毛片| 女人十人毛片免费观看3o分钟| 国产成人一区二区在线| 嫩草影院新地址| 亚洲性久久影院| 狂野欧美激情性xxxx在线观看| 午夜视频国产福利| 国产亚洲最大av| 亚洲三级黄色毛片| 精品久久久久久久久av| 少妇的逼水好多| 欧美另类一区| 日日摸夜夜添夜夜添av毛片| 免费看美女性在线毛片视频| 99re6热这里在线精品视频| 最近视频中文字幕2019在线8| 波多野结衣巨乳人妻| 黑人高潮一二区| 国产成人a区在线观看| 最近最新中文字幕免费大全7| 精品久久久久久久久久久久久| 久久精品夜夜夜夜夜久久蜜豆| 亚洲人成网站在线播| 久久精品夜夜夜夜夜久久蜜豆| 亚洲国产成人一精品久久久| 婷婷六月久久综合丁香| 亚洲天堂国产精品一区在线| av又黄又爽大尺度在线免费看| videos熟女内射| 国产 亚洲一区二区三区 | 亚洲人成网站在线播| 在线观看一区二区三区| 又爽又黄a免费视频| 免费av毛片视频| 国产乱人偷精品视频| 日日撸夜夜添| 中文字幕久久专区| av一本久久久久| 免费av观看视频| 日韩强制内射视频| 一个人看视频在线观看www免费| 国产黄片视频在线免费观看| 国内精品一区二区在线观看| av国产久精品久网站免费入址| 大陆偷拍与自拍| 一本久久精品| 寂寞人妻少妇视频99o| 国产片特级美女逼逼视频| 男的添女的下面高潮视频| 国产人妻一区二区三区在| 22中文网久久字幕| 建设人人有责人人尽责人人享有的 | 中文字幕免费在线视频6| 少妇丰满av| 别揉我奶头 嗯啊视频| 亚洲国产av新网站| 免费黄频网站在线观看国产| 国产精品人妻久久久影院| 精品一区二区三卡| 国产视频首页在线观看| 欧美激情国产日韩精品一区| 久久韩国三级中文字幕| 肉色欧美久久久久久久蜜桃 | 成年女人在线观看亚洲视频 | 韩国高清视频一区二区三区| eeuss影院久久| 免费黄网站久久成人精品| 婷婷六月久久综合丁香| 国产成人精品一,二区| 有码 亚洲区| 免费av观看视频| 精品久久久久久久末码| 日本免费在线观看一区| 一本一本综合久久| 久久久亚洲精品成人影院| 国产中年淑女户外野战色| 黄片无遮挡物在线观看| 内地一区二区视频在线| 精品一区二区免费观看| 精品国内亚洲2022精品成人| 成人漫画全彩无遮挡| 国产一区二区三区综合在线观看 | 成人午夜高清在线视频| 色网站视频免费| 国产精品熟女久久久久浪| 日韩人妻高清精品专区| 一级av片app| 亚洲欧洲国产日韩| 亚洲人成网站高清观看| 综合色av麻豆| 欧美激情久久久久久爽电影| 精品久久久精品久久久| 国产永久视频网站| 欧美丝袜亚洲另类| 日韩不卡一区二区三区视频在线| 成人美女网站在线观看视频| 久久久精品欧美日韩精品| 亚洲欧美日韩东京热| 久久午夜福利片| 身体一侧抽搐| 久久精品国产亚洲网站| 26uuu在线亚洲综合色| 直男gayav资源| xxx大片免费视频| 人人妻人人看人人澡| 搡老妇女老女人老熟妇| 国产av码专区亚洲av| 人妻少妇偷人精品九色| 91av网一区二区| 亚洲国产精品国产精品| 一级片'在线观看视频| 亚洲人成网站在线观看播放| 国产高清有码在线观看视频| 夜夜看夜夜爽夜夜摸| 日韩 亚洲 欧美在线| 91aial.com中文字幕在线观看| 内地一区二区视频在线| 一级片'在线观看视频| 国产亚洲精品av在线| 一二三四中文在线观看免费高清| 国产精品一区二区性色av| 亚洲aⅴ乱码一区二区在线播放| 国产老妇女一区| 亚洲国产精品成人久久小说| 少妇人妻一区二区三区视频| 在线观看人妻少妇| or卡值多少钱| 黄色日韩在线| 国产成人aa在线观看| 亚洲熟女精品中文字幕| 丝袜喷水一区| 中国国产av一级| 女人久久www免费人成看片| 国产亚洲精品久久久com| 日韩av在线免费看完整版不卡| 如何舔出高潮| 亚洲18禁久久av| 日韩在线高清观看一区二区三区| av卡一久久| 国产女主播在线喷水免费视频网站 | 大话2 男鬼变身卡| a级毛色黄片| 美女主播在线视频| 国产成人a区在线观看| 嫩草影院精品99| 色综合色国产| 简卡轻食公司| 欧美日韩精品成人综合77777| 最近最新中文字幕大全电影3| 成人特级av手机在线观看| 免费大片黄手机在线观看| 毛片女人毛片| 国产午夜精品久久久久久一区二区三区| 直男gayav资源| 亚洲国产欧美人成| 国产精品.久久久| 久久久色成人| 91av网一区二区| 久久久a久久爽久久v久久| or卡值多少钱| 三级男女做爰猛烈吃奶摸视频| 精品人妻熟女av久视频| 26uuu在线亚洲综合色| 天堂网av新在线| 听说在线观看完整版免费高清| 波野结衣二区三区在线| 国产麻豆成人av免费视频| 26uuu在线亚洲综合色| 欧美97在线视频| 一个人免费在线观看电影| 99视频精品全部免费 在线| 亚洲精品成人av观看孕妇| 亚洲美女视频黄频| 小蜜桃在线观看免费完整版高清| 91精品伊人久久大香线蕉| 国产高清不卡午夜福利| 成人无遮挡网站| 国产高清不卡午夜福利| 亚洲欧美日韩卡通动漫| 国内精品一区二区在线观看| 超碰av人人做人人爽久久| 中文资源天堂在线| 嫩草影院精品99| 亚洲性久久影院| 最近中文字幕高清免费大全6| 国产探花极品一区二区| 校园人妻丝袜中文字幕| 日韩,欧美,国产一区二区三区| 18禁在线播放成人免费| 久久久久免费精品人妻一区二区| 国产综合精华液| 不卡视频在线观看欧美| 最近中文字幕高清免费大全6| 久久鲁丝午夜福利片| 久久亚洲国产成人精品v| 欧美性猛交╳xxx乱大交人| 搞女人的毛片| av国产久精品久网站免费入址| 欧美精品一区二区大全| 蜜桃久久精品国产亚洲av| 国产精品三级大全| 伦理电影大哥的女人| 午夜爱爱视频在线播放| 亚洲乱码一区二区免费版| 亚洲久久久久久中文字幕| 菩萨蛮人人尽说江南好唐韦庄| 又黄又爽又刺激的免费视频.| 国产国拍精品亚洲av在线观看| kizo精华| 国产黄色小视频在线观看| 欧美不卡视频在线免费观看| 免费观看无遮挡的男女| 九九在线视频观看精品| 2021少妇久久久久久久久久久| ponron亚洲| 麻豆精品久久久久久蜜桃| av国产免费在线观看| 久久久久久久久久久丰满| 夫妻午夜视频| 免费无遮挡裸体视频| 亚洲精品成人av观看孕妇| 一级毛片 在线播放| 高清视频免费观看一区二区 | 国产一级毛片七仙女欲春2| 国产美女午夜福利| 美女大奶头视频| 亚洲久久久久久中文字幕| 在线免费观看的www视频| 欧美97在线视频| 久久久久久国产a免费观看| 欧美变态另类bdsm刘玥| 观看美女的网站| 国产白丝娇喘喷水9色精品| 精品久久久久久久末码| 精品熟女少妇av免费看| 国产人妻一区二区三区在| 婷婷色麻豆天堂久久| 国产精品久久久久久久久免| 亚洲av成人精品一二三区| 久久久a久久爽久久v久久| 国产亚洲午夜精品一区二区久久 | 欧美最新免费一区二区三区| 国内精品宾馆在线| 久久久久久九九精品二区国产| 成年免费大片在线观看| 欧美日韩精品成人综合77777| 国产综合懂色| 一级毛片电影观看| 夫妻性生交免费视频一级片| 国产精品一二三区在线看| 亚洲av福利一区| 亚洲经典国产精华液单| 色视频www国产| 亚洲av成人av| 波野结衣二区三区在线| 亚洲一区高清亚洲精品| 一边亲一边摸免费视频| 日本熟妇午夜| 久99久视频精品免费| 黄片wwwwww| 成人美女网站在线观看视频| 欧美性猛交╳xxx乱大交人| 人人妻人人澡人人爽人人夜夜 | 少妇的逼水好多| 一个人免费在线观看电影| 国产av码专区亚洲av| 欧美 日韩 精品 国产| 一级片'在线观看视频| av天堂中文字幕网| a级毛色黄片| 麻豆乱淫一区二区| 亚洲国产av新网站| 午夜免费观看性视频| 日本av手机在线免费观看| 网址你懂的国产日韩在线| 午夜免费激情av| 国产亚洲5aaaaa淫片| 18禁动态无遮挡网站|